News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Conference News EuroPCR 2023 Two New Renal Denervation Systems Look Good in Uncontrolled BP Todd Neale May 17, 2023
Presentation EuroPCR 2022 Blood pressure and MACE reductions after renal denervation: 3-year GSR results Presenter: Felix Mahfoud May 20, 2022
News Conference News EuroPCR 2022 Registry Data Hint at MACE Benefit With Renal Denervation Michael O'Riordan May 17, 2022
News Conference News EuroPCR 2020 DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions Todd Neale June 30, 2020
News Conference News EuroPCR 2020 New Data Add to Resurgent Renal Denervation Field Todd Neale June 26, 2020
News Conference News EuroPCR 2019 Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation L.A. McKeown June 06, 2019
News Conference News EuroPCR 2019 MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT Shelley Wood May 21, 2019
News Conference News EuroPCR 2018 STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP? Caitlin E. Cox May 31, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Conference News EuroPCR 2014 SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings Yael L. Maxwell May 22, 2014
News Conference News EuroPCR 2014 Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients Yael L. Maxwell May 22, 2014